Regulatory Insights
-
Advancing Patient Healthcare: Clarifying The 2019 Changes In India’s Drug And Clinical Trial Rules
3/29/2021
The Ministry of Health and Family Welfare, responsible for all health policy in India, took steps to clarify their regulatory requirements and address many of sponsors’ concerns with the publication of its New Drugs and Clinical Trials Rules in 2019. With these changes, it is worthwhile for sponsors, especially biotech and specialty pharmaceutical companies, to consider the many opportunities that India and other Asia-Pacific countries offer. We have summarized some of the most significant changes in this article.
This website uses cookies to ensure you get the best experience on our website. Learn more